These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2657105)

  • 21. A prospective double-blind trial of intracorporeal papaverine versus prostaglandin E1 in the treatment of impotence.
    Sarosdy MF; Hudnall CH; Erickson DR; Hardin TC; Novicki DE
    J Urol; 1989 Mar; 141(3):551-3. PubMed ID: 2645420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.
    Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P
    J Sex Med; 2013 Jun; 10(6):1612-27. PubMed ID: 23551886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral and transcutaneous pharmacologic agents in the treatment of impotence.
    Morales A; Condra MS; Owen JE; Fenemore J; Surridge DH
    Urol Clin North Am; 1988 Feb; 15(1):87-93. PubMed ID: 3125645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Yohimbine in the treatment of erectile disorder.
    Riley AJ
    Br J Clin Pract; 1994; 48(3):133-6. PubMed ID: 8031688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Yohimbine in the treatment of erectile dysfunction].
    Pushkar' DIu; Segal AS; Bagaev AG; Nosovitskiĭ PB
    Urologiia; 2002; (6):34-7. PubMed ID: 12577576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of low testosterone on response to treatment with tadalafil 5 mg once daily for erectile dysfunction.
    Goldfischer ER; Kim ED; Seftel AD; Baygani SK; Burns PR
    Urology; 2014 Jun; 83(6):1326-33. PubMed ID: 24726311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of impotence by intrapenile injections. A comparison of papaverine versus papaverine and phentolamine: a double-blind, crossover trial.
    Keogh EJ; Watters GR; Earle CM; Carati CJ; Wisniewski ZS; Tulloch GS; Lord DJ
    J Urol; 1989 Sep; 142(3):726-8. PubMed ID: 2671414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transdermal therapy of erectile insufficiency].
    Canale D; Cilurzo P; Giorgi PM; Menchini Fabris GF
    Arch Ital Urol Nefrol Androl; 1992 Sep; 64(3):263-6. PubMed ID: 1439854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Yohimbine: time for resurrection?
    Lancet; 1986 Nov; 2(8517):1194-5. PubMed ID: 2877331
    [No Abstract]   [Full Text] [Related]  

  • 30. A randomized crossover study using yohimbine and isoxsuprine versus pentoxifylline in the management of vasculogenic impotence.
    Knoll LD; Benson RC; Bilhartz DL; Minich PJ; Furlow WL
    J Urol; 1996 Jan; 155(1):144-6. PubMed ID: 7490815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In men with erectile dysfunction, satisfaction with quality of erections correlates with erection hardness, treatment satisfaction, and emotional well-being.
    Kaminetsky JC; Depko AJ; Ströberg P; Buvat J; Tseng LJ; Stecher VJ
    J Sex Med; 2009 Mar; 6(3):800-8. PubMed ID: 19143914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trial of pentoxifylline for diabetic impotence.
    Georgitis WJ; Merenich JA
    Diabetes Care; 1995 Mar; 18(3):345-52. PubMed ID: 7555478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biweekly intracavernous administration of papaverine for erectile dysfunction.
    Mooradian AD; Morley JE; Kaiser FE; Davis SS; Viosca SP; Korenman SC
    West J Med; 1989 Nov; 151(5):515-7. PubMed ID: 2603417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yohimbine in erectile dysfunction: the facts.
    Morales A
    Int J Impot Res; 2000 Mar; 12 Suppl 1():S70-74. PubMed ID: 10845767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological erection: diagnosis and treatment applications in 69 patients.
    Nellans RE; Ellis LR; Kramer-Levien D
    J Urol; 1987 Jul; 138(1):52-4. PubMed ID: 2439712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Yohimbine and psychogenic impotence.
    Lancet; 1987 Nov; 2(8567):1088. PubMed ID: 2889995
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficiency and side effects of prostaglandin E1 in the treatment of erectile dysfunction.
    Waldhauser M; Schramek P
    J Urol; 1988 Sep; 140(3):525-7. PubMed ID: 3045341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erectile dysfunction.
    O'Leary M
    Clin Evid; 2002 Jun; (7):796-803. PubMed ID: 12230705
    [No Abstract]   [Full Text] [Related]  

  • 39. The unreliability of nocturnal penile tumescence recording as an outcome measurement in the treatment of organic impotence.
    Condra M; Morales A; Surridge DH; Owen JA; Marshall P; Fenemore J
    J Urol; 1986 Feb; 135(2):280-2. PubMed ID: 3944859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of yohimbine on sexual function].
    Gorbov VG
    Urol Nefrol (Mosk); 1991; (4):74-6. PubMed ID: 1949423
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.